PBBG Investor Event at the Breakers - Tonix Pharmaceuticals

Recently, we held an investor dinner at a special venue that we normally reserve for our annual breakfast.  We hosted Tonix Pharmaceuticals (www.tonixpharma.com), and listened to their CEO, Seth Lederman, speak about his company's progress on the development of an FDA-designated Breakthrough Therapy for Post-Traumatic Stress Disorder (PTSD) medication, aimed at improving the quality of REM sleep that is frequently interrupted in individuals (especially those seeing combat) suffering PTSD.  This interruption of the REM sleep cycle may prevent the brain's "coping" process necessary to "get over" a traumatic experience.  Pictures from the event are posted below.  We hope to have Seth return next year and give us an update as to Tonix's progress!

No votes yet
Rate this page